SCA
PFE icon

SAC Capital Advisors’s Pfizer PFE Stock Holding History

SAC Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-311,736
Closed -$9.5M – 751
2014
Q1 		$9.5M Buy
311,736
+202,546
+185% +$6.04M 0.05% 415
2013
Q4 		$3.17M Sell
109,190
-10,783
-9% -$314K 0.02% 595
2013
Q3 		$3.27M Sell
119,973
-1,657,424
-93% -$45.1M 0.02% 623
2013
Q2 		$47.2M Buy
+1,777,397
New +$49.1M 0.26% 108

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

SAC Capital Advisors's PFE Position: Q2 2014 in Review

SAC Capital Advisors sold out of Pfizer (PFE) in Q2 2014, closing a stake of 311,736 shares — an estimated $9.5M sold.

SAC Capital Advisors first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $47.2M in Q2 2013. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • SAC Capital Advisors reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 311,736 Pfizer shares in Q2 2014, an estimated $9.5M.
  • SAC Capital Advisors first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Pfizer position peaked at $47.2M in Q2 2013.
  • 1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.